RT @felixredondofj: El contro glucemico intensivo no tiene efecto legado en la DM2. Cuando se igualan las HbA1c se igualan los riesgos!!! h…
El contro glucemico intensivo no tiene efecto legado en la DM2. Cuando se igualan las HbA1c se igualan los riesgos!!! https://t.co/2vjjCxi6EB
Control intensivo de la glucosa en pacientes con diabetes tipo 2—15 años de seguimiento https://t.co/n9tRO8eyAf PMID 31167051
We would like to think what we do makes a difference! However, intensive glucose control briefly likely doesn't have any outcome long term. #diabetesmelitus #diabetesweek #VA https://t.co/ueGKn40OOU
RT @Melhor_Prevenir: Perda do benefício após curvas de Hb1Ac se juntarem. Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Y…
@mikejohansenmd @raj_mehta @Info_Mastery @ProfHayward https://t.co/ICkaI5AhyD https://t.co/goHkcLpLqi https://t.co/BBjwC1tGH3 https://t.co/raGcSDQqay Not all of these are worth an hour or should change everything you do, but they add up to something.
Perda do benefício após curvas de Hb1Ac se juntarem. Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up | NEJM https://t.co/tw7ikYqRot https://t.co/YK9kxMEZ8n
Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up | NEJM https://t.co/IXX56NsFLl
RT @TheMedFiles: Intensive #glucose control vs. standard glucose control in patients with #Diabetes (T2DM) had no difference on the rates o…
Intensive #glucose control vs. standard glucose control in patients with #Diabetes (T2DM) had no difference on the rates of major cardiovascular events such as heart attack, #stroke and congestive heart failure. https://t.co/b6plK1WWio
2型糖尿病の強化療法vs標準療法の15年追跡。 追跡期間で、強化療法群の心血管イベントリスクの有意な低下は認められなかった。 VADT試験。 https://t.co/Zjyx3kl2ZT
New Pub! Reaven et al. in NEJM: Cardiovascular Benefits of Intensive Glucose Control Did Not Persist in Long-term VA Post-Trial (15 year) Follow-Up. https://t.co/3ZTabt3qLE
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up | NEJM https://t.co/xwwKxJe1O0
5,6年の集中的な血糖コントロールによるレガシー効果により心血管イベントが減少していた。15年追跡調査。 Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up. https://t.co/LiVfBEjDe2
@ProfHayward and colleagues report no 'legacy benefits' with intensive glycemic control in extended follow-up in this week's @NEJM.
Ernüchternde Langzeit-Follow-up Studie: Kardiovaskulärer Benefit einer intensiven Blutzuckereinstellung mit Insulin nur solange man diese beibehält. #USBEndo https://t.co/whNRMeNLIV
RT @NEJM: The VADT follow-up study was designed to examine long-term consequences of intensive glycemic control on cardiovascular disease o…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
Intensive Glucose Control in Patients with Type 2 #Diabetes — 15-Year Follow-up https://t.co/AyhpjtNHP4 https://t.co/iEdJFpFw5Z
RT @accpamedprn: Full 15-year follow-up results of intensive glucose control in Veterans with Type 2 Diabetes released! #amedprn https://t…
Full 15-year follow-up results of intensive glucose control in Veterans with Type 2 Diabetes released! #amedprn https://t.co/WssVVz8shr
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
This is disappointing. https://t.co/2bYpzpcxHl
@CardiologiahoyC - El riesgo de eventos cardiovasculares mayores se redujo durante el intervalo donde las curvas de hemoglobina glicosilada estuvieron separadas - Este beneficio no continuó después de su ecualizació (índice de riesgo, 1.26; IC 95%, 0.90 a
Those and other articles from the latest edition of the @NEJM are available in the libraries in York and Scarborough . Come to visit us #YorkNHSLibrary 🙂
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @IlindelatorreMD: Control glucémico intensivo no produjo beneficio cardiovascular persistente | NEJM https://t.co/h2iE2ROGut
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
Participants with type 2 diabetes who had been randomly assigned to intensive glucose control for 5.6 years had a lower risk of cardiovascular events than those who received standard therapy only during the prolonged period in which the glycated hemoglobin
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @KSusztak: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up | NEJM https://t.co/q199nxCDov
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @IlindelatorreMD: Control glucémico intensivo no produjo beneficio cardiovascular persistente | NEJM https://t.co/h2iE2ROGut
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
RT @NEJM: Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editori…
Original Article: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/3ToeVW3Vhe Editorial: Lack of Glycemic Legacy Effects in the Veterans Affairs Diabetes Trial https://t.co/NRQges6wZZ https://t.co/gkfbgfAJ1p
RT @Toyoakisawano: 先週のNEJM 強化インスリン療法の15年間のコホート追跡。5.6年間の治療期間中の心血管イベントは減少したが、その後の観察期間では有意差はなくなりlegacy effectはないという結果。 https://t.co/YzSCoHxlRT
先週のNEJM 強化インスリン療法の15年間のコホート追跡。5.6年間の治療期間中の心血管イベントは減少したが、その後の観察期間では有意差はなくなりlegacy effectはないという結果。 https://t.co/YzSCoHxlRT
RT @IlindelatorreMD: Control glucémico intensivo no produjo beneficio cardiovascular persistente | NEJM https://t.co/h2iE2ROGut
RT @IlindelatorreMD: Control glucémico intensivo no produjo beneficio cardiovascular persistente | NEJM https://t.co/h2iE2ROGut
RT @SABOURETCardio: Crucial for T2D patients management : the ODIACOR registry will provide contemporary data about T2D pts with CAD. @CNCF…
Crucial for T2D patients management : the ODIACOR registry will provide contemporary data about T2D pts with CAD. @CNCFCardio @GaitaDan @DrABINASR @SFDiabete @DocSylviePicard @FZores @GARCIAEDINSON95 @GiuseppeGalati_ @ShelleyZieroth @drbrowncares @HcmMsc @
RT @IlindelatorreMD: Control glucémico intensivo no produjo beneficio cardiovascular persistente | NEJM https://t.co/h2iE2ROGut
RT @CristobMorales: https://t.co/L0mYl4aCQs T2DM with intensive glucose control for 5.6 years had a lower risk of CV events than those who…
RT @IlindelatorreMD: Control glucémico intensivo no produjo beneficio cardiovascular persistente | NEJM https://t.co/h2iE2ROGut
RT @IlindelatorreMD: Control glucémico intensivo no produjo beneficio cardiovascular persistente | NEJM https://t.co/h2iE2ROGut
RT @IlindelatorreMD: Control glucémico intensivo no produjo beneficio cardiovascular persistente | NEJM https://t.co/h2iE2ROGut
RT @IlindelatorreMD: Control glucémico intensivo no produjo beneficio cardiovascular persistente | NEJM https://t.co/h2iE2ROGut
Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up | NEJM https://t.co/q199nxCDov
RT @IlindelatorreMD: Control glucémico intensivo no produjo beneficio cardiovascular persistente | NEJM https://t.co/h2iE2ROGut
Control glucémico intensivo no produjo beneficio cardiovascular persistente | NEJM https://t.co/h2iE2ROGut
RT @CristobMorales: https://t.co/L0mYl4aCQs T2DM with intensive glucose control for 5.6 years had a lower risk of CV events than those who…
Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up | NEJM https://t.co/zg2SWfVpUA
RT @rafabravo: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up | NEJM https://t.co/Z1dPw9r0jW
RT @NEVasquez92: No legacy effect on CVD outcomes for intensive glucose control in diabetes https://t.co/CjK9kjCeSF
RT @rafabravo: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up | NEJM https://t.co/Z1dPw9r0jW
RT @hmbaquero: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up | NEJM https://t.co/RE1uOC0cao
RT @CristobMorales: https://t.co/L0mYl4aCQs T2DM with intensive glucose control for 5.6 years had a lower risk of CV events than those who…
RT @Dr_Khan: Intensive Glucose Control in Patients with Type 2 Diabetes — 15-Year Follow-up https://t.co/eVeqHbWYeM /via @NEJM
RT @ggimenezendocri: https://t.co/j08q1Du1iD Guidance Statement 2: Clinicians should aim to achieve an HbA1c level between 7% and 8% in mos…